Ipca Laboratories Limited
IPCALAB
Peringkat dalam Saham
#3404
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Harga Saham
$20.02
Terakhir disinkronkan: 2026-10-19
Kapitalisasi Pasar
$5.08B
Perubahan (1 hari)
-1.65%
Perubahan (1 tahun)
38.46%
Negara
IN
Perdagangan Ipca Laboratories Limited (IPCALAB)
Kategori
Healthcare
Rasio P/S untuk Ipca Laboratories Limited (IPCALAB)
Rasio P/S per October 2026 TTM: 4.79
Menurut laporan keuangan dan harga saham terbaru dari Ipca Laboratories Limited, rasio P/S saat ini (TTM) adalah 4.79. Pada akhir 2024, rasio P/S perusahaan adalah 4.09.
Riwayat rasio P/S untuk Ipca Laboratories Limited dari 2005 hingga 2026
Rasio P/S pada akhir setiap tahun
| Tahun | Rasio P/S | Mengubah |
|---|---|---|
| 2026 (TTM) | 4.79 | 21.18% |
| 2025 | 3.95 | -3.41% |
| 2024 | 4.09 | 23.36% |
| 2023 | 3.31 | -29.36% |
| 2022 | 4.69 | 4.36% |
| 2021 | 4.49 | 16.46% |
| 2020 | 3.86 | 15.92% |
| 2019 | 3.33 | 27.17% |
| 2018 | 2.62 | 2.84% |
| 2017 | 2.55 | -1.43% |
| 2016 | 2.58 | 0.29% |
| 2015 | 2.57 | -21.59% |
| 2014 | 3.28 | 37.60% |
| 2013 | 2.39 | 33.22% |
| 2012 | 1.79 | -9.72% |
| 2011 | 1.98 | -7.96% |
| 2010 | 2.16 | 233.52% |
| 2009 | 0.65 | -56.00% |
| 2008 | 1.47 | -8.30% |
| 2007 | 1.60 | 38.75% |
| 2006 | 1.15 | 4.46% |
| 2005 | 1.11 | 0.00% |
Rasio P/S untuk perusahaan sejenis atau pesaing
| Perusahaan | Rasio P/S | Perbedaan Rasio P/S | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 47.45% |
IN
|
